{
  "generatedAt": "2026-01-29T00:02:25.723Z",
  "weekOf": "2026-01-27",
  "summary": {
    "totalPending": 1,
    "bySource": {
      "cms": 1,
      "payers": 0,
      "vendor": 0
    }
  },
  "crawlerHealth": {
    "cms": {
      "lastRun": "2026-01-28T23:17:46.000Z",
      "lastSuccess": "2026-01-28T23:18:27.000Z",
      "discoveriesFound": 1,
      "discoveriesAdded": 1,
      "duration": 41000,
      "status": "success",
      "updatedAt": "2026-01-28T23:18:27.000Z"
    },
    "payers": {
      "lastRun": "2026-01-28T23:19:47.000Z",
      "lastSuccess": "2026-01-28T23:23:35.000Z",
      "discoveriesFound": 0,
      "discoveriesAdded": 0,
      "duration": 228000,
      "status": "success",
      "updatedAt": "2026-01-28T23:23:35.000Z"
    },
    "vendor": {
      "lastRun": "2026-01-28T23:18:27.000Z",
      "lastSuccess": "2026-01-28T23:19:47.000Z",
      "discoveriesFound": 0,
      "discoveriesAdded": 0,
      "duration": 80000,
      "status": "success",
      "updatedAt": "2026-01-28T23:19:47.000Z"
    }
  },
  "discoveries": [
    {
      "id": "disc_test_001",
      "source": "cms",
      "type": "medicare_lcd_update",
      "title": "Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies",
      "summary": "Updated billing article for MolDX NGS LDTs covering myeloid malignancies. Claude analysis: This is a billing/coding article (not coverage policy). It updates CPT code guidance for NGS testing in myeloid cancers. No direct coverage changes but clarifies billing requirements.",
      "url": "https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=59879",
      "discoveredAt": "2026-01-28T23:18:27.000Z",
      "data": {
        "documentType": "Article",
        "documentId": "A59879",
        "contractor": "Palmetto GBA (MolDX)",
        "affectedTests": [
          "NGS LDTs for myeloid malignancies"
        ],
        "moldxRelevant": true,
        "coverageDecision": "billing_guidance",
        "keyChanges": "Updated billing codes and documentation requirements for NGS-based myeloid testing"
      }
    }
  ]
}